Report cover image

Global Canine Vaccine Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Jul 01, 2025
Length 198 Pages
SKU # APRC20117839

Description

Summary

According to APO Research, the global Canine Vaccine market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Canine Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Canine Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Canine Vaccine market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Canine Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Canine Vaccine market include Biogenesis Bago, Boehringer Ingelheim, Durvet, NeoTech, Virbac, Pfizer, Jilin Five-Star Animal Health, JINHE and Wuhan Keqian Biology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Canine Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Canine Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Canine Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Canine Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Canine Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Canine Vaccine sales, projected growth trends, production technology, application and end-user industry.

Canine Vaccine Segment by Company

Biogenesis Bago
Boehringer Ingelheim
Durvet
NeoTech
Virbac
Pfizer
Jilin Five-Star Animal Health
JINHE
Wuhan Keqian Biology
SINOVAC
Elanco
Merck Animal Health
RuiPu Bio-Technology
Zoetis
CAHIC

Canine Vaccine Segment by Type

Core Vaccines
Non-Core Vaccines

Canine Vaccine Segment by Application

Puppies
Adult Dogs

Canine Vaccine Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global Canine Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Canine Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Canine Vaccine significant trends, drivers, influence factors in global and regions.
6. To analyze Canine Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Canine Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Canine Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Canine Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Canine Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Canine Vaccine industry.
Chapter 3: Detailed analysis of Canine Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Canine Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Canine Vaccine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

198 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Canine Vaccine Sales Value (2020-2031)
1.2.2 Global Canine Vaccine Sales Volume (2020-2031)
1.2.3 Global Canine Vaccine Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Canine Vaccine Market Dynamics
2.1 Canine Vaccine Industry Trends
2.2 Canine Vaccine Industry Drivers
2.3 Canine Vaccine Industry Opportunities and Challenges
2.4 Canine Vaccine Industry Restraints
3 Canine Vaccine Market by Company
3.1 Global Canine Vaccine Company Revenue Ranking in 2024
3.2 Global Canine Vaccine Revenue by Company (2020-2025)
3.3 Global Canine Vaccine Sales Volume by Company (2020-2025)
3.4 Global Canine Vaccine Average Price by Company (2020-2025)
3.5 Global Canine Vaccine Company Ranking (2023-2025)
3.6 Global Canine Vaccine Company Manufacturing Base and Headquarters
3.7 Global Canine Vaccine Company Product Type and Application
3.8 Global Canine Vaccine Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Canine Vaccine Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Canine Vaccine Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Canine Vaccine Market by Type
4.1 Canine Vaccine Type Introduction
4.1.1 Core Vaccines
4.1.2 Non-Core Vaccines
4.2 Global Canine Vaccine Sales Volume by Type
4.2.1 Global Canine Vaccine Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Canine Vaccine Sales Volume by Type (2020-2031)
4.2.3 Global Canine Vaccine Sales Volume Share by Type (2020-2031)
4.3 Global Canine Vaccine Sales Value by Type
4.3.1 Global Canine Vaccine Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Canine Vaccine Sales Value by Type (2020-2031)
4.3.3 Global Canine Vaccine Sales Value Share by Type (2020-2031)
5 Canine Vaccine Market by Application
5.1 Canine Vaccine Application Introduction
5.1.1 Puppies
5.1.2 Adult Dogs
5.2 Global Canine Vaccine Sales Volume by Application
5.2.1 Global Canine Vaccine Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Canine Vaccine Sales Volume by Application (2020-2031)
5.2.3 Global Canine Vaccine Sales Volume Share by Application (2020-2031)
5.3 Global Canine Vaccine Sales Value by Application
5.3.1 Global Canine Vaccine Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Canine Vaccine Sales Value by Application (2020-2031)
5.3.3 Global Canine Vaccine Sales Value Share by Application (2020-2031)
6 Canine Vaccine Regional Sales and Value Analysis
6.1 Global Canine Vaccine Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Canine Vaccine Sales by Region (2020-2031)
6.2.1 Global Canine Vaccine Sales by Region: 2020-2025
6.2.2 Global Canine Vaccine Sales by Region (2026-2031)
6.3 Global Canine Vaccine Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Canine Vaccine Sales Value by Region (2020-2031)
6.4.1 Global Canine Vaccine Sales Value by Region: 2020-2025
6.4.2 Global Canine Vaccine Sales Value by Region (2026-2031)
6.5 Global Canine Vaccine Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Canine Vaccine Sales Value (2020-2031)
6.6.2 North America Canine Vaccine Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Canine Vaccine Sales Value (2020-2031)
6.7.2 Europe Canine Vaccine Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Canine Vaccine Sales Value (2020-2031)
6.8.2 Asia-Pacific Canine Vaccine Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Canine Vaccine Sales Value (2020-2031)
6.9.2 South America Canine Vaccine Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Canine Vaccine Sales Value (2020-2031)
6.10.2 Middle East & Africa Canine Vaccine Sales Value Share by Country, 2024 VS 2031
7 Canine Vaccine Country-level Sales and Value Analysis
7.1 Global Canine Vaccine Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Canine Vaccine Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Canine Vaccine Sales by Country (2020-2031)
7.3.1 Global Canine Vaccine Sales by Country (2020-2025)
7.3.2 Global Canine Vaccine Sales by Country (2026-2031)
7.4 Global Canine Vaccine Sales Value by Country (2020-2031)
7.4.1 Global Canine Vaccine Sales Value by Country (2020-2025)
7.4.2 Global Canine Vaccine Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Canine Vaccine Sales Value Growth Rate (2020-2031)
7.5.2 USA Canine Vaccine Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Canine Vaccine Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Canine Vaccine Sales Value Growth Rate (2020-2031)
7.6.2 Canada Canine Vaccine Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Canine Vaccine Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Canine Vaccine Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Canine Vaccine Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Canine Vaccine Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Canine Vaccine Sales Value Growth Rate (2020-2031)
7.8.2 Germany Canine Vaccine Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Canine Vaccine Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Canine Vaccine Sales Value Growth Rate (2020-2031)
7.9.2 France Canine Vaccine Sales Value Share by Type, 2024 VS 2031
7.9.3 France Canine Vaccine Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Canine Vaccine Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Canine Vaccine Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Canine Vaccine Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Canine Vaccine Sales Value Growth Rate (2020-2031)
7.11.2 Italy Canine Vaccine Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Canine Vaccine Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Canine Vaccine Sales Value Growth Rate (2020-2031)
7.12.2 Spain Canine Vaccine Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Canine Vaccine Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Canine Vaccine Sales Value Growth Rate (2020-2031)
7.13.2 Russia Canine Vaccine Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Canine Vaccine Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Canine Vaccine Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Canine Vaccine Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Canine Vaccine Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Canine Vaccine Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Canine Vaccine Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Canine Vaccine Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Canine Vaccine Sales Value Growth Rate (2020-2031)
7.16.2 China Canine Vaccine Sales Value Share by Type, 2024 VS 2031
7.16.3 China Canine Vaccine Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Canine Vaccine Sales Value Growth Rate (2020-2031)
7.17.2 Japan Canine Vaccine Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Canine Vaccine Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Canine Vaccine Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Canine Vaccine Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Canine Vaccine Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Canine Vaccine Sales Value Growth Rate (2020-2031)
7.19.2 India Canine Vaccine Sales Value Share by Type, 2024 VS 2031
7.19.3 India Canine Vaccine Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Canine Vaccine Sales Value Growth Rate (2020-2031)
7.20.2 Australia Canine Vaccine Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Canine Vaccine Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Canine Vaccine Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Canine Vaccine Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Canine Vaccine Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Canine Vaccine Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Canine Vaccine Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Canine Vaccine Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Canine Vaccine Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Canine Vaccine Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Canine Vaccine Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Canine Vaccine Sales Value Growth Rate (2020-2031)
7.24.2 Chile Canine Vaccine Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Canine Vaccine Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Canine Vaccine Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Canine Vaccine Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Canine Vaccine Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Canine Vaccine Sales Value Growth Rate (2020-2031)
7.26.2 Peru Canine Vaccine Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Canine Vaccine Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Canine Vaccine Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Canine Vaccine Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Canine Vaccine Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Canine Vaccine Sales Value Growth Rate (2020-2031)
7.28.2 Israel Canine Vaccine Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Canine Vaccine Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Canine Vaccine Sales Value Growth Rate (2020-2031)
7.29.2 UAE Canine Vaccine Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Canine Vaccine Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Canine Vaccine Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Canine Vaccine Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Canine Vaccine Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Canine Vaccine Sales Value Growth Rate (2020-2031)
7.31.2 Iran Canine Vaccine Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Canine Vaccine Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Canine Vaccine Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Canine Vaccine Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Canine Vaccine Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Biogenesis Bago
8.1.1 Biogenesis Bago Comapny Information
8.1.2 Biogenesis Bago Business Overview
8.1.3 Biogenesis Bago Canine Vaccine Sales, Value and Gross Margin (2020-2025)
8.1.4 Biogenesis Bago Canine Vaccine Product Portfolio
8.1.5 Biogenesis Bago Recent Developments
8.2 Boehringer Ingelheim
8.2.1 Boehringer Ingelheim Comapny Information
8.2.2 Boehringer Ingelheim Business Overview
8.2.3 Boehringer Ingelheim Canine Vaccine Sales, Value and Gross Margin (2020-2025)
8.2.4 Boehringer Ingelheim Canine Vaccine Product Portfolio
8.2.5 Boehringer Ingelheim Recent Developments
8.3 Durvet
8.3.1 Durvet Comapny Information
8.3.2 Durvet Business Overview
8.3.3 Durvet Canine Vaccine Sales, Value and Gross Margin (2020-2025)
8.3.4 Durvet Canine Vaccine Product Portfolio
8.3.5 Durvet Recent Developments
8.4 NeoTech
8.4.1 NeoTech Comapny Information
8.4.2 NeoTech Business Overview
8.4.3 NeoTech Canine Vaccine Sales, Value and Gross Margin (2020-2025)
8.4.4 NeoTech Canine Vaccine Product Portfolio
8.4.5 NeoTech Recent Developments
8.5 Virbac
8.5.1 Virbac Comapny Information
8.5.2 Virbac Business Overview
8.5.3 Virbac Canine Vaccine Sales, Value and Gross Margin (2020-2025)
8.5.4 Virbac Canine Vaccine Product Portfolio
8.5.5 Virbac Recent Developments
8.6 Pfizer
8.6.1 Pfizer Comapny Information
8.6.2 Pfizer Business Overview
8.6.3 Pfizer Canine Vaccine Sales, Value and Gross Margin (2020-2025)
8.6.4 Pfizer Canine Vaccine Product Portfolio
8.6.5 Pfizer Recent Developments
8.7 Jilin Five-Star Animal Health
8.7.1 Jilin Five-Star Animal Health Comapny Information
8.7.2 Jilin Five-Star Animal Health Business Overview
8.7.3 Jilin Five-Star Animal Health Canine Vaccine Sales, Value and Gross Margin (2020-2025)
8.7.4 Jilin Five-Star Animal Health Canine Vaccine Product Portfolio
8.7.5 Jilin Five-Star Animal Health Recent Developments
8.8 JINHE
8.8.1 JINHE Comapny Information
8.8.2 JINHE Business Overview
8.8.3 JINHE Canine Vaccine Sales, Value and Gross Margin (2020-2025)
8.8.4 JINHE Canine Vaccine Product Portfolio
8.8.5 JINHE Recent Developments
8.9 Wuhan Keqian Biology
8.9.1 Wuhan Keqian Biology Comapny Information
8.9.2 Wuhan Keqian Biology Business Overview
8.9.3 Wuhan Keqian Biology Canine Vaccine Sales, Value and Gross Margin (2020-2025)
8.9.4 Wuhan Keqian Biology Canine Vaccine Product Portfolio
8.9.5 Wuhan Keqian Biology Recent Developments
8.10 SINOVAC
8.10.1 SINOVAC Comapny Information
8.10.2 SINOVAC Business Overview
8.10.3 SINOVAC Canine Vaccine Sales, Value and Gross Margin (2020-2025)
8.10.4 SINOVAC Canine Vaccine Product Portfolio
8.10.5 SINOVAC Recent Developments
8.11 Elanco
8.11.1 Elanco Comapny Information
8.11.2 Elanco Business Overview
8.11.3 Elanco Canine Vaccine Sales, Value and Gross Margin (2020-2025)
8.11.4 Elanco Canine Vaccine Product Portfolio
8.11.5 Elanco Recent Developments
8.12 Merck Animal Health
8.12.1 Merck Animal Health Comapny Information
8.12.2 Merck Animal Health Business Overview
8.12.3 Merck Animal Health Canine Vaccine Sales, Value and Gross Margin (2020-2025)
8.12.4 Merck Animal Health Canine Vaccine Product Portfolio
8.12.5 Merck Animal Health Recent Developments
8.13 RuiPu Bio-Technology
8.13.1 RuiPu Bio-Technology Comapny Information
8.13.2 RuiPu Bio-Technology Business Overview
8.13.3 RuiPu Bio-Technology Canine Vaccine Sales, Value and Gross Margin (2020-2025)
8.13.4 RuiPu Bio-Technology Canine Vaccine Product Portfolio
8.13.5 RuiPu Bio-Technology Recent Developments
8.14 Zoetis
8.14.1 Zoetis Comapny Information
8.14.2 Zoetis Business Overview
8.14.3 Zoetis Canine Vaccine Sales, Value and Gross Margin (2020-2025)
8.14.4 Zoetis Canine Vaccine Product Portfolio
8.14.5 Zoetis Recent Developments
8.15 CAHIC
8.15.1 CAHIC Comapny Information
8.15.2 CAHIC Business Overview
8.15.3 CAHIC Canine Vaccine Sales, Value and Gross Margin (2020-2025)
8.15.4 CAHIC Canine Vaccine Product Portfolio
8.15.5 CAHIC Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Canine Vaccine Value Chain Analysis
9.1.1 Canine Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Canine Vaccine Sales Mode & Process
9.2 Canine Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Canine Vaccine Distributors
9.2.3 Canine Vaccine Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.